Karyopharm Reports First Quarter 2015 Financial Results and Highlights Recent Progress
May 11, 2015 07:00 ET
|
Karyopharm Therapeutics
Positive Data in Difficult to Treat Cancers With Significant Unmet Need Further Supports Broad Clinical Development Campaign for Selinexor
Conference Call Scheduled for Today at 8:30 a.m....
Karyopharm to Present at Bank of America Merrill Lynch 2015 Healthcare Conference
May 07, 2015 08:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that Michael G. Kauffman, MD, PhD, Chief Executive...
Karyopharm to Report First Quarter 2015 Financial Results on May 11, 2015
May 05, 2015 08:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., May 5, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that it will report first quarter 2015 financial...
Karyopharm to Present Late-Breaking Data at American Association for Cancer Research Annual Meeting
April 17, 2015 16:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., April 17, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that two late-breaking abstracts describing the...
Karyopharm Granted U.S. Composition-of-Matter Patent for Selinexor (KPT-330)
April 13, 2015 08:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., April 13, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the issuance of U.S. Patent No. 8,999,996...
Karyopharm Appoints Mikael Dolsten, MD, PhD to Its Board of Directors
April 01, 2015 08:00 ET
|
Karyopharm Therapeutics
NEWTON, Mass., April 1, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the appointment of Mikael Dolsten, MD, PhD,...
Karyopharm to Present Data on Its Novel Oral PAK4 Allosteric Modulator (PAM) at the American Association for Cancer Research Annual Meeting
March 18, 2015 16:37 ET
|
Karyopharm Therapeutics
NEWTON, Mass., March 18, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that five abstracts describing the company's PAK4...
Karyopharm to Present Data on Oncology Pipeline at American Association for Cancer Research Annual Meeting
March 18, 2015 16:36 ET
|
Karyopharm Therapeutics
NEWTON, Mass., March 18, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that fourteen abstracts describing the activity...
Karyopharm Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Recent Progress
March 16, 2015 07:00 ET
|
Karyopharm Therapeutics
Initiated Multiple Registration-directed Trials and Presented Positive Selinexor Clinical Data in 2014
Aggressive Selinexor Development Campaign Continues in 2015
Conference Call Scheduled for...
Karyopharm to Report Fourth Quarter and Full Year 2014 Financial Results on March 16, 2015
March 09, 2015 08:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., March 9, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that it will report fourth quarter and year ended...